Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

By Hlavaty Juraj   Jandl Gerrit   Liszt Melissa   Petznek Helga   König-Schuster Marielle   Sedlak Jenny   Egerbacher Monika   Weissenberger Jakob   Salmons Brian   Günzburg Walter   Renner Matthias  

Journal of Neuro-Oncology, Vol. 102, Iss. 1, 2011-03 ,pp. : 59-69

Springer Publishing Company

Access to resources Recommend Favorite

Oncolytic virotherapy for gliomas: steps toward the future

By Kaufmann Johanna K   Chiocca E Antonio  

CNS Oncology, Vol. 2, Iss. 5, 2013-09 ,pp. : 389-392

Future Medicine

Access to resources Recommend Favorite

Conditionally replicating oncolytic adenoviral vector expressing arresten and tumor necrosis factor-related apoptosis-inducing ligand experimentally suppresses lung carcinoma progression

By              

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2068-2074

Spandidos Publications

Access to resources Recommend Favorite

Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA

By            

International Journal of Oncology, Vol. 47, Iss. 2, 2015-01 ,pp. : 668-678

Spandidos Publications

Access to resources Recommend Favorite

Anticancer Effect of PS-T on the Experimental Hepatocellular Carcinoma

By Chen Li   Lu Peng   Lu Zhengxin   Li Dechun  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 55-59

Springer Publishing Company

Access to resources Recommend Favorite